98%
921
2 minutes
20
Background: Preprectoral breast reconstruction and nipple-sparing mastectomy (NSM) have both risen in popularity due to advances in reconstructive techniques. However, it is unknown whether exposed lactiferous ducts in a NSM may increase the risk for infection after prepectoral implant-based breast reconstruction. We aimed to assess complication rates and BREAST-Q Physical Well-Being of the Chest (PWBC) scores in patients who underwent NSM and implant-based breast reconstruction in a prepectoral vs. submuscular plane.
Methods: A retrospective review was performed of patients who underwent NSM with two-stage implant-based reconstruction from 2013-2023. Patients were grouped by prepectoral or submuscular placement. Post-operative complications and BREAST-Q scores were assessed after surgery.
Results: 693 patients were included; 345 underwent prepectoral and 348 underwent submuscular reconstruction. Surgical site infection occurred in 10% of prepectoral patients and 5.7% of submuscular patients (p=0.03). Seroma occurred in 15% of prepectoral patients and 6.6% submuscular patients (p<0.001). Multivariable analysis showed prepectoral patients had significantly increased odds of developing surgical site infection and seroma compared to submuscular patients (Odds ratio [OR] 1.87, p=0.04 and OR 2.52, p<0.001, respectively). However, prepectoral reconstruction was associated with significantly higher BREAST-Q PWBC scores as compared to submuscular implant placement (β=3.4, p=0.01).
Conclusions: Prepectoral reconstruction following NSM is associated with higher rates of surgical site infection and seroma but improved physical well-being of the chest compared to submuscular implant placement following NSM. An increased risk of infection and seroma should be weighed against improved patient-reported outcomes when deciding on implant plane placement after NSM.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/PRS.0000000000012096 | DOI Listing |
Ann Surg Oncol
September 2025
Section of Surgical Oncology, Department of Surgery, Washington University School of Medicine, St. Louis, MO, USA.
Background: Postmastectomy autologous reconstruction (PMAR) is an important component of comprehensive breast cancer care. Previous research has suggested the existence of sociodemographic disparities in complications after immediate PMAR. The objective of this study was to examine the impact of sociodemographic and clinical factors on immediate PMAR postoperative outcomes.
View Article and Find Full Text PDFJ Surg Case Rep
September 2025
Division of Plastic and Reconstructive Surgery, University of California, Los Angeles, 200 Medical Plaza, Suite 460, Los Angeles, CA 90095, United States.
Tuberous breast deformity was first documented by Rees and Aston in 1976. The deformity is well documented in cisgender women, with rare cases in cisgender men often associated with gynecomastia, and almost no reports in transgender women. Herein, we present a case of a 32-year-old transgender woman who developed bilateral tuberous breast deformity after 10 years of hormone replacement therapy.
View Article and Find Full Text PDFCureus
August 2025
Medicine, Academy of Silesia, Katowice, POL.
We present the case of a 45-year-old Caucasian woman diagnosed with synchronous bicentric breast cancer of differing molecular phenotypes in the same breast. The first tumor, an invasive ductal carcinoma (G1), was estrogen and progesterone receptor-positive and HER2-negative, with a low proliferative index (Ki67 10%). A second lesion, located in a different quadrant and appearing within weeks after biopsy, exhibited a triple-negative phenotype and a higher proliferative index (Ki67 30%).
View Article and Find Full Text PDFMedicine (Baltimore)
September 2025
Department of Medical and Pharmaceutical Affairs, Doctor CONSULT, Seoul, Korea.
Stakeholders in the breast implant industry in Korea have recently experienced a crisis from breast implant-associated anaplastic large cell lymphoma and the first Korean case of a medical device fraud. We compared the short-term safety between the microtextured devices that are commercially available after the occurrence of breast implant crisis in Korea. The current study was conducted in a cohort of Korean women who had received an implant-based augmentation mammaplasty for aesthetic purposes between November 14, 2020 and October 13, 2022.
View Article and Find Full Text PDFAdv Sci (Weinh)
September 2025
Department of Chemical and Biological Engineering, Department of Chemistry, Hong Kong Branch of Chinese National Engineering Research Center for Tissue Restoration and Reconstruction, State Key Laboratory of Molecular Neuroscience, The Hong Kong University of Science & Technology, Hong Kong, 999077,
Breast cancer (BC), characterized by its heterogeneity and diverse subtypes, necessitates personalized treatment strategies. This study presents MF3Ec-TBPP nanoparticles (NPs) as a promising approach, integrating an aggregation-induced emission (AIE)-based photosensitizer, TBPP, with the MF3Ec aptamer to enhance targeted photodynamic therapy (PDT) for Luminal A subtype BC cells. The nanoparticles also feature a 1, 2-distearoyl-sn-glycero-3-phosphoethanolamine-poly(ethylene glycol) shell and dipalmitoyl phosphatidylcholine (DPPC), which stabilize the structure and inhibit singlet oxygen generation, effectively reducing off-target effects and protecting healthy tissues.
View Article and Find Full Text PDF